Please assess the completion status of the following clinical trial:

Trial Title: Assessing Parathyroid Glands Vascularisation by ICG Fluoroscopy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patients undergoing total thyroidectomy or a totalisation thyroid procedure.~* Patients capable of understanding and able to understand the study.~* Values visually 2 and ICG 2~Exclusion Criteria:~* Parathyroid disease or prior parathyroidectomy~* Lack of informed consent~* Altered mental status of the patient.~* ICG values \<2.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- New treatment (Type: EXPERIMENTAL): In patients with at least one well perfused parathyroid gland on ICG parathyroid angiography, no postoperative parathyroid dosage and supplementation will be done. Calcium and parathormone dosage will be done 10 days after surgery.
- Standart treatment (Type: ACTIVE_COMPARATOR): In those patients in whom at least on of the four parathyroid glands is well perused, postoperative parathyroid function test and parathyroid supplementation will be done. Calcium and parathormone dosage will be done at 24 hours and 10 days after surgery. Prophylactic supplementation of calcium and Vitamin D will be given.

Based on this trial design, predict the completion outcome and termination type (if applicable).